|
|
Other links at Articles > Pharmacists |
| 2. |
Surfactant Protein D Reduced by Fluticasone in COPD
|
|
|
Although fluticasone with or without salmeterol does not alter systemic markers of inflammation in patients with COPD, the drugs do result in a significant reduction in the serum levels of the lung-specific surfactant protein D, Canadian researchers report. Reuters Health Information
|
| 4. |
Everolimus Effective in Rheumatoid Arthritis Patients
|
|
|
The proliferation signal inhibitor everolimus is effective and safe in rheumatoid arthritis (RA) patients who have an inadequate response to methotrexate, according to trial results reported in the August issue of the Annals of the Rheumatic Diseases. However, development of everolimus for this indication is not being pursued. Reuters Health Information
|
| 5. |
Etanercept Appears Effective, Well Tolerated for Giant Cell Arteritis
|
|
|
Etanercept may potentially replace corticosteroid therapy for patients with giant cell arteritis (GCA) who are experiencing adverse effects from the corticosteroid, according to the first randomized, double-blind, placebo-controlled trial of etanercept in patients with GCA. Reuters Health Information
|
|
|
